Nimustine hydrochloride CAS 55661-38-6

Nimustine hydrochloride (Nimustine hydrochloride), relieve the role of self-conscious

symptom and signs of the following diseases: brain cervical cancer, brain cancer, lung

cancer, digestive tract cancer (cancer of the stomach, colon/rectal cancer, esophageal

cancer, malignant lymphoma and leukemia, etc.

Clinical research

Ease self-conscious symptom and signs of the following diseases: brain cervical cancer,

brain cancer, lung cancer, digestive tract cancer (cancer of the stomach, colon/rectal

cancer, esophageal cancer), malignant lymphoma and leukemia, etc.

Storage method

Avoid light, cool dark save

Announcements

–Shall not be used for subcutaneous or intramuscular injection. 2. Intravenous drug use, if

liquid leakage from blood vessels, sometimes will cause the injection site scleroma, necrosis

, so careful injection in order to avoid liquid leakage from blood vessels. 3. This product

with light easy to decompose, aqueous solution is not stable, dissolved immediately after

use. 4. Agent mixed with him and sometimes cause change, so pay attention to.

–General note: (1) sometimes slow seere side effects such as bone marrow inhibition, at

least six weeks after the treatment should be performed weekly clinical inspection (e.g.,

blood tests, liver function and renal function of procuratorial), fully the symptoms were

observed. If discovery is unusual, should reduce dosage or withdrawal of appropriate

treatment. In addition, the long-term use can aggravate the side effect was found to goes

on, so careful medication. (2) pay attention to the infection diseases fully, the occurrence

of bleeding tendency and deteriorating. (3) the pediatric drug use should be discreet, by the

appearance of the side effects should be paid attention to. (4) children and patients of reproductive

age, should pay attention to the influence of the gonads. 2. The following patients cannot use: (1)

in patients with bone marrow suppression (2) patients with past history to our agent have severe allergies.

Safety information

Dangerous mark T Risk category code: 25

Safety instructions: 36/37/39-45

Dangerous goods transportation number: UN 2811